William V Kastrinakis, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anastomosis, Surgical | 1 | 2024 | 982 | 0.180 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2024 | 509 | 0.180 |
Why?
|
| Inappropriate Prescribing | 1 | 2019 | 212 | 0.140 |
Why?
|
| Interdisciplinary Communication | 1 | 2019 | 931 | 0.110 |
Why?
|
| Genes, p53 | 1 | 1995 | 713 | 0.110 |
Why?
|
| Genes, ras | 1 | 1995 | 654 | 0.100 |
Why?
|
| Point Mutation | 1 | 1995 | 1593 | 0.090 |
Why?
|
| Liver Neoplasms | 2 | 1995 | 4309 | 0.080 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 1741 | 0.080 |
Why?
|
| Caregivers | 1 | 2021 | 2244 | 0.080 |
Why?
|
| Colorectal Neoplasms | 3 | 1995 | 6919 | 0.060 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 2164 | 0.060 |
Why?
|
| Colectomy | 1 | 2009 | 686 | 0.060 |
Why?
|
| Forms and Records Control | 1 | 2005 | 158 | 0.060 |
Why?
|
| Codon | 2 | 1995 | 597 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3805 | 0.050 |
Why?
|
| Pancreatic Ducts | 1 | 2024 | 329 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7400 | 0.050 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2005 | 385 | 0.050 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2005 | 571 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2009 | 2220 | 0.040 |
Why?
|
| Exons | 2 | 1995 | 2380 | 0.040 |
Why?
|
| Drug Utilization Review | 1 | 2019 | 248 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 3691 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 1995 | 6341 | 0.040 |
Why?
|
| Base Sequence | 3 | 1995 | 12404 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 6067 | 0.030 |
Why?
|
| Tunicamycin | 1 | 1995 | 108 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 1995 | 17598 | 0.030 |
Why?
|
| Drug Resistance, Multiple | 1 | 1995 | 255 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 2854 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 3 | 1995 | 6124 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2019 | 1141 | 0.030 |
Why?
|
| Weight Loss | 1 | 2005 | 2680 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2019 | 990 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 22140 | 0.020 |
Why?
|
| DNA Primers | 1 | 1995 | 2814 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1995 | 1057 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2021 | 3024 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 1668 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1995 | 1743 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2019 | 3549 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2019 | 2688 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 1995 | 982 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2021 | 2493 | 0.020 |
Why?
|
| Hospitals | 1 | 2021 | 3881 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2009 | 15637 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1995 | 1967 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2024 | 5366 | 0.020 |
Why?
|
| Unnecessary Procedures | 1 | 2009 | 418 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2021 | 4320 | 0.020 |
Why?
|
| MEDLINE | 1 | 2005 | 119 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 2009 | 526 | 0.010 |
Why?
|
| Device Removal | 1 | 2009 | 629 | 0.010 |
Why?
|
| Cell Line | 2 | 1995 | 15545 | 0.010 |
Why?
|
| Carotid Artery Diseases | 1 | 1991 | 877 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 1995 | 4243 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 13402 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1995 | 2527 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1995 | 2223 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2009 | 1303 | 0.010 |
Why?
|
| Humans | 10 | 2024 | 761208 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1995 | 5782 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 2164 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 1664 | 0.010 |
Why?
|
| United States | 2 | 2019 | 72339 | 0.010 |
Why?
|
| Logistic Models | 1 | 2009 | 13249 | 0.010 |
Why?
|
| Prognosis | 1 | 1995 | 29687 | 0.010 |
Why?
|
| Mutation | 2 | 1995 | 30002 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 1995 | 367 | 0.010 |
Why?
|
| Glycosylation | 1 | 1995 | 1095 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 1995 | 671 | 0.010 |
Why?
|
| Middle Aged | 2 | 2019 | 220853 | 0.010 |
Why?
|
| Cadherins | 1 | 1995 | 902 | 0.010 |
Why?
|
| Life Tables | 1 | 1991 | 364 | 0.010 |
Why?
|
| Endarterectomy | 1 | 1991 | 196 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1995 | 5032 | 0.000 |
Why?
|
| Constriction, Pathologic | 1 | 1991 | 1097 | 0.000 |
Why?
|
| Male | 2 | 2019 | 360693 | 0.000 |
Why?
|
| Carotid Arteries | 1 | 1991 | 941 | 0.000 |
Why?
|
| Female | 2 | 2019 | 392544 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1995 | 3661 | 0.000 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1995 | 2915 | 0.000 |
Why?
|
| Adult | 1 | 2019 | 221119 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1995 | 5871 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1995 | 8300 | 0.000 |
Why?
|
| Cerebrovascular Disorders | 1 | 1991 | 1474 | 0.000 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1995 | 4513 | 0.000 |
Why?
|
| Gene Expression | 1 | 1995 | 7571 | 0.000 |
Why?
|
| Obesity | 1 | 2005 | 12939 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1995 | 11067 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2009 | 80674 | 0.000 |
Why?
|
| Reoperation | 1 | 1991 | 4303 | 0.000 |
Why?
|
| Disease Progression | 1 | 1995 | 13511 | 0.000 |
Why?
|
| Recurrence | 1 | 1991 | 8457 | 0.000 |
Why?
|
| Phenotype | 1 | 1995 | 16575 | 0.000 |
Why?
|
| Sex Factors | 1 | 1991 | 10553 | 0.000 |
Why?
|
| Aged | 1 | 2009 | 169288 | 0.000 |
Why?
|
| Incidence | 1 | 1991 | 21365 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1991 | 39126 | 0.000 |
Why?
|
| Time Factors | 1 | 1991 | 39957 | 0.000 |
Why?
|